[go: up one dir, main page]

PA8658201A1 - Formulaciones inyectables o administrables por via oral de derivados de azetidina - Google Patents

Formulaciones inyectables o administrables por via oral de derivados de azetidina

Info

Publication number
PA8658201A1
PA8658201A1 PA20058658201A PA8658201A PA8658201A1 PA 8658201 A1 PA8658201 A1 PA 8658201A1 PA 20058658201 A PA20058658201 A PA 20058658201A PA 8658201 A PA8658201 A PA 8658201A PA 8658201 A1 PA8658201 A1 PA 8658201A1
Authority
PA
Panama
Prior art keywords
derivatives
injectable
oral route
azetidina
administrable formulations
Prior art date
Application number
PA20058658201A
Other languages
English (en)
Inventor
Sophie Cote
Maria-Teresa Peracchia
Gilbert Gaudel
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8658201A1 publication Critical patent/PA8658201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMULACIONES BINARIAS O TERNARIAS INYECTABLES O ADMINISTRABLES POR VIA ORAL DE DERIVADOS DE AZETIDINA. LOS DERIVADOS DE AZETIDINA UTILIZADOS EN LAS COMPOSICIONES FARMACEUTICAS SEGUN LA INVENCION PUEDEN DESIGNARSE POR LAS FORMULAS GENERALES (IA) O (IB) A CONTINUACION: EN LAS QUE AR ES UN GRUPO AROMATICO O HETEROAROMATICO OPCIONALMENTE SUSTITUIDO POR UNO O VARIOS ALQUILO (C1-C4), HALOGENO, NO2, CN, ALCOXI(C1-C4) U OH.
PA20058658201A 2004-12-27 2005-12-22 Formulaciones inyectables o administrables por via oral de derivados de azetidina PA8658201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0413937A FR2879932B1 (fr) 2004-12-27 2004-12-27 Formulations injectable ou administrable par voie orale de derives d'azetidine

Publications (1)

Publication Number Publication Date
PA8658201A1 true PA8658201A1 (es) 2006-08-03

Family

ID=34952941

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058658201A PA8658201A1 (es) 2004-12-27 2005-12-22 Formulaciones inyectables o administrables por via oral de derivados de azetidina

Country Status (20)

Country Link
US (2) US20070244085A1 (es)
EP (1) EP1835906A1 (es)
JP (1) JP2008525390A (es)
KR (1) KR20070092970A (es)
CN (1) CN101090719A (es)
AR (1) AR052181A1 (es)
AU (1) AU2005321112A1 (es)
BR (1) BRPI0519271A2 (es)
CA (1) CA2586895A1 (es)
FR (1) FR2879932B1 (es)
GT (1) GT200500387A (es)
IL (1) IL183483A0 (es)
MX (1) MX2007006926A (es)
PA (1) PA8658201A1 (es)
PE (1) PE20060743A1 (es)
RU (1) RU2007128812A (es)
SV (1) SV2006002355A (es)
TW (1) TW200635581A (es)
UY (1) UY29318A1 (es)
WO (1) WO2006070129A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2334285A1 (en) * 2008-09-12 2011-06-22 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
US9918965B2 (en) 2015-04-10 2018-03-20 Bioresponse, L.L.C. Self-emulsifying formulations of DIM-related indoles
WO2020257336A1 (en) 2019-06-18 2020-12-24 Opiant Pharmaceuticals, Inc. Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0177158B1 (ko) * 1990-03-01 1999-03-20 후지사와 도모기찌로 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제
US5516770A (en) * 1993-09-30 1996-05-14 American Home Products Corporation Rapamycin formulation for IV injection
MXPA01011981A (es) * 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
US20100022501A1 (en) 2010-01-28
GT200500387A (es) 2006-07-03
TW200635581A (en) 2006-10-16
MX2007006926A (es) 2007-08-06
RU2007128812A (ru) 2009-02-10
JP2008525390A (ja) 2008-07-17
SV2006002355A (es) 2006-06-28
FR2879932A1 (fr) 2006-06-30
AR052181A1 (es) 2007-03-07
KR20070092970A (ko) 2007-09-14
CA2586895A1 (fr) 2006-07-06
CN101090719A (zh) 2007-12-19
US20070244085A1 (en) 2007-10-18
UY29318A1 (es) 2006-07-31
WO2006070129A1 (fr) 2006-07-06
EP1835906A1 (fr) 2007-09-26
FR2879932B1 (fr) 2007-03-23
BRPI0519271A2 (pt) 2009-01-06
PE20060743A1 (es) 2006-09-13
AU2005321112A1 (en) 2006-07-06
IL183483A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
HN2012001162A (es) Triazolopiridinas
NO20081724L (no) Stabil farmasoytisk sammensetning omfattende et pyrimidin-sulfamid
NO20075111L (no) Farmasoytisk sammensetning
GT200900001A (es) Composicion farmaceutica que contiene un acido tetra hidrofolico
NO20090175L (no) Stabile laquinimod sammensetninger
UY31457A1 (es) Derivados acidos de cicloalquilamino
DOP2007000092A (es) Derivados de cicloalquilaminoácidos
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
AR062109A1 (es) Derivados sustituidos de espirocetal y uso de los mismos como farmacos terapeuticos para la diabetes. composiciones farmaceuticas.
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
MA30765B1 (fr) Derives innovants du thiophene
CR10027A (es) Nuevos derivados de pirrol fusionado
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
NI200900042A (es) Nuevo derivados de dismetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
CR9590A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamida su prepracion y su aplicacion en terapeutica
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
DK1797088T3 (da) Hidtil ukendte chromen-2-on-derivater og anvendelse heraf som monoamin-neurotransmitter-genoptagelseshæmmere
ECSP066304A (es) Compuestos
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
PA8658201A1 (es) Formulaciones inyectables o administrables por via oral de derivados de azetidina
BRPI0607645A2 (pt) sais de derivados de hexaidrofenantridina substituìdos com 6-heterociclila